Today's Veterinary Business

DEC 2018

Today’s Veterinary Business provides information and resources designed to help veterinarians and office management improve the financial performance of their practices, allowing them to increase the level of patient care and client service.

Issue link:

Contents of this Issue


Page 18 of 69

62. No matter what your patients are focused on, PROZINC is the ideal insulin choice that meets their individual needs. That's because PROZINC puts diabetic cats fi rst, with e cacy proven to improve clinical signs, 1 a duration of action appropriate for felines, 2,3 and expert veterinary support. PROZINC is focused on details that make the di erence. Formulated with veterinary- approved protamine zinc insulin PROZINC has a 10–14 hour duration of e• ect, 3 the desired duration of action for cats 2 O• ers owners a convenient, twice-a-day treatment protocol, with injections that can be 12 hours apart The ONLY AAHA-recommended and FDA-approved insulin for the initial treatment of diabetic cats 1 Provides predictable glycemic control and e‰ cacy proven to improve clinical signs 1 Owners receive early and e• ective management of their cats' feline diabetes mellitus Designed to be used with the U-40 syringe For small insulin doses, U-40 syringes are more accurate and precise than U-100 syringes 4 Cats are less likely to experience clinically important over- or underdosing 4 IMPORTANT SAFETY INFORMATION: For use in cats only. Animals presenting with severe ketoacidosis, anorexia, lethargy, and/or vomiting should be stabilized with short-acting insulin and appropriate supportive therapy until their condition is stabilized. As with all insulin products, careful patient monitoring for hypoglycemia and hyperglycemia is essential to attain and maintain adequate glycemic control and to prevent associated complications. Overdosage can result in profound hypoglycemia and death. Progestogen and glucocorticoid use should be avoided. PROZINC is contraindicated in cats during episodes of hypoglycemia and in cats sensitive to protamine zinc recombinant human insulin or any other ingredient in the PROZINC product. Please see Brief Summary on page 65. 17.

Articles in this issue

Archives of this issue

view archives of Today's Veterinary Business - DEC 2018